IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Innate Immunotherapeutics LT

CUSIP: Q4934F101 | 1 institutional holders

Quarters

Q2 2018Q1 2018Q4 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2018

QCI Asset Management Inc60,000
0.0% of portfolio›$13
StyleTurnoverLocationFiled
QCI Asset Management Inc
60,000$130.0%N/AN/APittsford, NY2018-08-06